Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review
Filippo Pennazio, Claudio Brasso, Vincenzo Villari, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2674-2674
Open Access | Times Cited: 19

Showing 19 citing articles:

Ultrasensitive detection of vital biomolecules based on a multi-purpose BioMEMS for Point of care testing: digoxin measurement as a case study
Fahimeh Marvi, Kian Jafari, Mahmoud Shahabadi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
One-pot synthesis of magnetic adsorbent with integrated pH regulation for convenient and rapid determination of antidepressant in biofluids
Zhanwu Li, Bowen Deng, Jiajia Chen, et al.
Microchemical Journal (2025), pp. 112834-112834
Closed Access
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
Pradeepraj Durairaj, Zixiang Liu
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 44-44
Open Access
Pharmacometabolomics: An emerging platform for understanding the pathophysiological processes and therapeutic interventions
Chandra Prakash, Patrick Moran, Rohit Mahar
International Journal of Pharmaceutics (2025), pp. 125554-125554
Closed Access
Long-acting antipsychotic treatments: focus on women with schizophrenia
Sofia Brissos, Vicent Balanzá‐Martínez
Therapeutic Advances in Psychopharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Investigation of cardiac arrhythmia events in patients treated with lamotrigine: FDA adverse event reporing system analysis
Mohammed Aboukaoud, Adi Wilf‐Yarkoni, Elad Maor
Epilepsia (2023) Vol. 64, Iss. 9, pp. 2322-2329
Open Access | Times Cited: 10
Towards Precision Medicine in Clinical Practice: Alinity C vs. UHPLC-MS/MS in Plasma Aripiprazole Determination
Francisco José Toja-Camba, Enrique Bandín‐Vilar, Gonzalo Hermelo-Vidal, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 104-104
Open Access | Times Cited: 3
Pharmacokinetic Simulation Study: Exploring the Impact of Clinical Parameters on Lamotrigine for Different Patient Populations with Implications for Liver Function Assessment and Therapeutic Drug Monitoring
Bárbara Costa, Isabel Silva, José Carlos Oliveira, et al.
Scientia Pharmaceutica (2024) Vol. 92, Iss. 1, pp. 15-15
Open Access | Times Cited: 2
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia
Kristen M. Ward, Leslie Citrome
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 4, pp. 399-409
Closed Access | Times Cited: 2
Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: A cross-sectional study
Merve Becit-Kızılkaya, Şeyma Öncü, Halit Buğra Koca, et al.
Epilepsy & Behavior (2024) Vol. 155, pp. 109802-109802
Closed Access | Times Cited: 2
Review of Male and Female Care Needs in Schizophrenia: A New Specialized Clinical Unit for Women
Alexandre González-Rodríguez, Mary V. Seeman, M. Natividad, et al.
Women (2023) Vol. 3, Iss. 1, pp. 107-120
Open Access | Times Cited: 6
Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse
Wonsuk Shin, Dong Hyeon Lee, Hyounggyoon Yoo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 882-882
Open Access | Times Cited: 1
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center
Letizia Biso, Marco Carli, Shivakumar Kolachalam, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 945-945
Open Access | Times Cited: 4
The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature
Francesco Weiss, Bruno Pacciardi, Giulia D’Alessandro, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 531-531
Open Access | Times Cited: 1
Advocating for the inclusion of therapeutic drug monitoring in the national essential diagnostic list: Perspectives from psychiatrists
Arpit Parmar, Arghya Pal
Indian Journal of Psychiatry (2024) Vol. 66, Iss. 7, pp. 660-664
Open Access | Times Cited: 1
Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
Gavriela Voulgaridou, Theodora Paraskeva, Georgia Ragia, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2181-2181
Open Access | Times Cited: 2
High-performance liquid chromatography-tandem mass spectrometry was used to measure 20 antidepressants in human serum
Huanchang Luo, Jianwei Zhou, Guanfeng Lin, et al.
Bioanalysis (2024) Vol. 16, Iss. 19-20, pp. 1033-1044
Closed Access
Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial
Chun-I Liu, Chih‐Min Liu, Huai-Hsuan Chiu, et al.
Psychological Medicine (2024) Vol. 54, Iss. 14, pp. 3906-3916
Closed Access
Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis
Saibal Das, Manoj Kalita, Manabendra Makhal, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
Page 1

Scroll to top